Axo Longevity raises $5M seed

◆ Amount

$5M

◆ Announced

15 Sept 2026

◆ Company

◆ Source

◆ The Round

Axo Longevity raised $5M in seed funding, announced on 15 September 2026, led by MS&AD Ventures, with participation from Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital, NIAN Sports & Entertainment. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Axo Longevity

A global preventive health membership platform offering comprehensive biomarker testing, personalized health blueprints and ongoing tracking across Europe and Latin America. Axo Longevity is based in United Kingdom and currently at seed stage, operating in Longevity & Wellness, Digital Health.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links Axo Longevity's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market